Ken Griffin Talis Biomedical Corp

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$109

Avg closing price
Price range
Ken Griffin Portfolio Stock Details (TLIS)

9 Ken Griffin Talis Biomedical Trades

The first Talis Biomedical trade was made in Q3 2021. Since then Ken Griffin bought shares four more times and sold shares on four occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in Talis Biomedical anymore.

Avg closing price
Price range
Sold -2.59 Thousand shares Q3 2023
Avg closing price $10.15
Price range $5.52 - $112.07
New holding (+2.59 Thousand shares) Q2 2023
Avg closing price $108.85
Price range $99.90 - $121.28
Sold -6.34 Thousand shares Q1 2023
Avg closing price $127.50
Price range $107.84 - $143.14
New holding (+6.34 Thousand shares) Q4 2022
Avg closing price $131.55
Price range $100.28 - $174.98
Sold -2.82 Thousand shares Q3 2022
Avg closing price $189.68
Price range $153.36 - $258.75
New holding (+2.82 Thousand shares) Q2 2022
Avg closing price $237.22
Price range $182.70 - $324.00
Sold -2.31 Thousand shares Q1 2022
Avg closing price $519.17
Price range $292.50 - $942.75
Increased shares by 32.7% (+570 shares) Q4 2021
Avg closing price $1,122.19
Price range $857.25 - $1,388.25
New holding (+1.74 Thousand shares) Q3 2021
Avg closing price $1,998.70
Price range $1,354.50 - $2,803.50
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.